Xu, Ruihua
Wang, Wei
Zhu, Bo
Lin, Xiaoyan
Ma, Dong
Zhu, Lingjun
Zhao, Qingchuan
Nie, Yongzhan
Cai, Xiaohong
Li, Qi
Fang, Weijia
Li, Hongyan
Wang, Ning
Chen, Yun
Peng, Cike
Fang, Honghao
Shen, Lin
Funding for this research was provided by:
Lilly Suzhou Pharmaceutical Company Limited
Article History
Received: 3 July 2019
Accepted: 20 January 2020
First Online: 18 February 2020
Ethics approval and consent to participate
: De-identification of personal information was performed at the data entry stage in the multi-center oncology database. Ethics approvals were obtained for this study from Beijing Cancer Hospital Ethics Committee, Sun Yat-sen University Cancer Center Ethics Committee and Xijing Hospital Ethics Committee. For hospitals that did not require ethics approval as a mandatory, a form of ‘Confidential and non-use Agreement’ was assigned. The informed consent was waived by the IRBs from all hospitals.The full names of hospitals that did not require ethics approval as a mandatory were:The First People’s Hospital of Foshan.Xinqiao Hospital, Third Military Medical University.Fujian Medical University Union Hospital.Guangdong General Hospital.Jiangsu Province Hospital.Sichuan Cancer Hospital and Institute.Shanghai General Hospital.The First Hospital of Zhejiang Province.
: Not applicable
: The authors declare that they have no competing interests.